Aevi Genomic Medicine Announces Agreement for $28 Million Private Placement

PHILADELPHIA, Aug. 10, 2017 -- (Healthcare Sales & Marketing Network) -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the "Company") today announced the execution of a definitive agreement to sell shares of common stock and warrants to purchase c... Biopharmaceuticals, Venture Capital Aevi Genomic Medicine, Crohn's disease
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news